MGIM
GSK icon

M&G Investment Management’s GSK GSK Stock Holding History

M&G Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,398
Closed -$636K – 468
2020
Q3 		$636K Sell
13,398
-11,864
-47% -$594K 0.01% 331
2020
Q2 		$1.29M Buy
+25,262
New +$1.3M 0.01% 284

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

M&G Investment Management's GSK Position: Q4 2020 in Review

M&G Investment Management sold out of GSK (GSK) in Q4 2020, closing a stake of 13,398 shares — an estimated $636K sold.

M&G Investment Management first reported a position in GSK in Q2 2020 and held it in 2 quarters. The position peaked at $1.29M in Q2 2020. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • M&G Investment Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • M&G Investment Management sold 13,398 GSK shares in Q4 2020, an estimated $636K.
  • M&G Investment Management first reported a position in GSK in Q2 2020 and held it in 2 quarters.
  • M&G Investment Management's GSK position peaked at $1.29M in Q2 2020.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on M&G Investment Management's 13F filing for Q4 2020, filed 2 Feb 2021.